- $6.45bn
- $4.98bn
- $1.61bn
Annual income statement for UiPath, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 892 | 1,059 | 1,308 | 1,430 | 1,611 |
| Cost of Revenue | |||||
| Gross Profit | 723 | 879 | 1,112 | 1,186 | 1,340 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,393 | 1,407 | 1,473 | 1,592 | 1,554 |
| Operating Profit | -501 | -348 | -165 | -163 | 56.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -511 | -318 | -75.8 | -78.1 | 101 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -526 | -328 | -89.9 | -73.7 | 282 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -526 | -328 | -89.9 | -73.7 | 282 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -526 | -328 | -89.9 | -73.7 | 282 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.16 | -0.571 | -0.156 | -0.103 | 0.523 |